https://www.selleckchem.com/pr....oducts/gsk-3008348-h
Since the introduction of an alkylator to the treatment of multiple myeloma (MM), new effective agents have been developed, such as immunomodulatory drugs including thalidomide, lenalidomide, and pomalidomide; proteasome inhibitors including bortezomib, carfilzomib, and ixazomib; monoclonal antibodies including daratumumab and elotuzumab; and deacetylase inhibitors including panobinostat. Numerous regimens with these new agents have been developed and they have contributed in improving survival outcomes in MM patients.
Vapemall Wholesale Co. UK – your trusted distributor for high-quality disposable vapes. Bulk boxes, top brands, unbeatable prices. We supply UK vape shops with fast dispatch & responsive support. Trade-only wholesale – no retail. #VapeWholesaleUK #Vapemall